The Trump administration officials downplayed the inclusion of a journalist in a group text about U.S. military plans, while some processing for green card applications has been suspended to increase vetting of applicants. Additionally, a new antibiotic called Blujepa was approved by the FDA to treat UTIs, marking the first new antibiotic for this condition in nearly 30 years.
During a Senate Intelligence Committee hearing, Trump’s intelligence officials downplayed the group text incident and defended the lawful nature of the communication. The suspension of green card processing for certain applicants, particularly those who were granted asylum, is part of an effort to comply with Trump’s executive order for increased vetting and screening of immigrants.
The FDA recently approved Blujepa, a new antibiotic to treat uncomplicated UTIs in women and girls 12 and older. This antibiotic belongs to a new class called triazaacenaphthylenes, targeting key enzymes in bacteria to prevent replication. The approval comes as bacteria causing UTIs are becoming resistant to standard antibiotics.
In other news, Russia and Ukraine have agreed to a ceasefire in the Black Sea, federal racketeering allegations against Sean “Diddy” Combs were dismissed, and new changes are expected in Major League Baseball including high-tech measures for balls and strikes. Lastly, The Selection newsletter by NBC provides product reviews and expert shopping tips.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
